delete too if neededFluge/Mella said:So then we did an open-label study with no placebo group with a maintenance treatment of further
Rituximab infusion prolonging the period of no B-cells we gave six infusions of Rituximab up to
fifteen months and then followed the patients for three years.
This study is now submitted for publication but we can say that again two-thirds had a clinical
response and their response durations were much prolonged when we gave maintenance
treatment.
Thanks to Russell Fleming for the transcript
delete too if needed